Assessment of efficacy of nasal drops as a medication of shadabindu tail in the management of hair fall.
Phase 3
- Conditions
- Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere
- Registration Number
- CTRI/2019/06/019741
- Lead Sponsor
- Minal sagar pawar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All the patients clinically diagnosed for hair fall last more than 3 months.
Patients ready to give written consent.
Exclusion Criteria
Genetic inheritance for hair fall.
k/o hypothyroidism and hyperthyroidism.
Patients associated with major illness.
Patient undergoing modern medicine treatment/any other treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Both subjective and clinical improvements would be employed for assessment of the impact of therapy. Subjective criteria of evaluation included the observations of both patients and assessment of the investigator. <br/ ><br>Assessment will be done according to changes in score of symptoms. Relevant statistical values would be used to determine the significance of the drug. Patients will be observed before, during and after treatment.Timepoint: The treatment will be given for one alternate day for 7 days i.e 1 cycle for 15 days. <br/ ><br>The next cycle will be started after the gap of 15 days. Three cycles of nasya will be given to the patient.
- Secondary Outcome Measures
Name Time Method -Timepoint: -